孕期脏功能障碍的孕产妇和胎儿结果及其预测因素
Shakir Ahmad1, Rudramani Swami1, Kalpana Mehta1
1Department of Nephrology, Topiwala National Medical College and BYL Nair Hospital, Mumbai, India.
概括
与怀孕相关的病,包括急性损伤 (AKI) 和慢性病 (CKD),存在重大风险. 通过定期产前护理进行早期检测和预防对于改善母亲和胎儿的结果至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 产科和妇科 产科和妇科
- 关键护理医学 关键护理医学
背景情况:
- 怀孕期间的脏疾病,包括急性损伤 (AKI) 和慢性病 (CKD),对母亲和胎儿的健康都有很大的风险.
- 这些疾病需要在专门的医疗保健机构内全面了解其流行病学和临床结果.
研究的目的:
- 调查与怀孕相关的AKI和CKD的流行病学和结果.
- 分析患有这些脏疾病的孕妇的孕妇和胎儿的结果.
主要方法:
- 一个回顾性研究在一个三级护理中心进行.
- 纳入标准包括怀孕妇女和产后6周内被诊断患有AKI或CKD的妇女,但不包括18岁以下的个人.
- 收集的数据包括母亲人口统计,妊娠年龄,损伤原因,治疗干预措施以及母亲/胎儿结局.
主要成果:
- 在70例病例中,55例患有AKI,10例患有AKI和CKD,还有5例患有CKD. 败血症和孕前是AKI的主要原因.
- 产妇死亡率为14.7% (10/68),其中48名母亲完全康复. 20名患者需要进行血液透析,导致6人死亡.
- 胎儿的结果很差,有35例胎儿死亡. 母亲因素如高血压,败血症,代谢性化症,胆红素升高,以及需要血液透析与母亲不良结果相关. 升高的胆红素与胎儿的不良结果有关.
结论:
- 与怀孕相关的AKI和CKD与显著的孕产妇和胎儿发病率和死亡率有关.
- 通过定期产前检查强调预防对于减轻这些风险至关重要.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
402
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
402
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Renal Failure: Dose Adjustments
407
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
407
Hormonal Regulation
35.6K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.6K
Acute Kidney Injury IV: Diagnostic Studies and Prevention
244
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
244
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
196
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
196


